VOR Earnings

Quarterly EPS
$-8.77
Q4 2024
$-5.21
Q1 2025
$-251.24
Q2 2025
$-121.63
Q3 2025
$84.87
Q4 2025
$-5.11
Q1 2026
$-1.16
Q2 2026
$-1.45
Q3 2026
Latest RevenueN/A
Latest Net Income-86727000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q3 2026-$1.450-86727000—+98.8%
Q2 2026-$1.160-62810000—+99.5%
Q1 2026-$5.110-219585000—+1.9%
Q4 2025$84.8701.7B—+1,067.7%
Q3 2025-$121.630-812684000—-1,410.9%
Q2 2025-$251.240-1573669000—-2,963.9%
Q1 2025-$5.210-32486000—+42.1%
Q4 2024-$8.770-30712000—-13.3%
Q3 2024-$8.050-27559000——
Q2 2024-$8.200-27839000——
Q1 2024-$9.000-30804000——
Q4 2023-$7.740-26261000——
Vor Biopharma (VOR) — Earnings